Brigham and Women's Hospital: Arthritis, Rheumatoid trials
The registry lists 27 Arthritis, Rheumatoid studies with Brigham and Women's Hospital as lead sponsor. 1 are open to participants now and 10 have results posted.
Phase 2 2Phase 3 1Phase 4 4No phase 20(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) StudyRecruitingNCT07315997
- Breaking Implicit Bias Habits: An Individuation Pilot Study In RheumatologyCompletedNCT05116163Not applicableResults posted
- Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)CompletedNCT02808871Phase 2Results posted
- Lipids, Inflammation, and CV Risk in RACompletedNCT02714881Results posted
- Treatments Against RA and Effect on FDG-PET/CTCompletedNCT02374021Phase 4Results posted
- Personalized Risk Estimator for Rheumatoid Arthritis Family StudyCompletedNCT02046005Not applicableResults posted
- Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA TrialCompletedNCT01400516Phase 4Results posted
- Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee PainCompletedNCT01351805Not applicableResults posted
- Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid ArthritisCompletedNCT01207453Phase 4Results posted
- Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid ArthritisCompletedNCT01132118Phase 3Results posted
- Living Well With Rheumatoid ArthritisCompletedNCT00869349Not applicableResults posted
- A Trial of Academic Detailing to Promote Prescribing of BiosimilarsActive, not recruitingNCT07221890Not applicable
- Rheumatology-based Adaptive Intervention for Social Determinants and Health EquityActive, not recruitingNCT05715463Not applicable
- People-Powered Medicine (PPM): Rheumatoid Arthritis Non-responders to Biologic Therapies (RANT)CompletedNCT05447182
- Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer EndpointsCompletedNCT04798287
- Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)- Cardiovascular EndpointsCompletedNCT04772248
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs HydroxychloroquineCompletedNCT04691505
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - TNFi vs AbataceptCompletedNCT04529902
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tofacitinib vs AbataceptCompletedNCT04529876
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tocilizumab vs AbataceptCompletedNCT04529863
- Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory ArthritisWithdrawnNCT04115020Phase 2
- A Novel Mobile App & Population Management System to Manage Rheumatoid Arthritis FlaresCompletedNCT02822521Not applicable
- Treat-to-target in RA: Collaboration To Improve adOption and adhereNceCompletedNCT02260778Not applicable
- The Health Log: A Randomized Clinical TrialCompletedNCT01913080Not applicable
- Brigham and Women's Rheumatoid Arthritis Sequential StudyActive, not recruitingNCT01793103
- Patient Rheumatoid Arthritis Social Support StudyTerminatedNCT01525654Not applicable
- Relaxation Response Training for the Treatment of Rheumatoid ArthritisCompletedNCT00056667Phase 4